Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Altimmune (ALT) over the last 8 years, with Q3 2025 value amounting to $177000.0.

  • Altimmune's Other Accumulated Expenses rose 22777.78% to $177000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $177000.0, marking a year-over-year increase of 22777.78%. This contributed to the annual value of $55000.0 for FY2024, which is 5564.52% down from last year.
  • According to the latest figures from Q3 2025, Altimmune's Other Accumulated Expenses is $177000.0, which was up 22777.78% from $183000.0 recorded in Q2 2025.
  • In the past 5 years, Altimmune's Other Accumulated Expenses ranged from a high of $183000.0 in Q2 2025 and a low of $54000.0 during Q3 2024
  • For the 4-year period, Altimmune's Other Accumulated Expenses averaged around $98555.6, with its median value being $69000.0 (2024).
  • In the last 5 years, Altimmune's Other Accumulated Expenses tumbled by 5564.52% in 2024 and then skyrocketed by 22777.78% in 2025.
  • Over the past 4 years, Altimmune's Other Accumulated Expenses (Quarter) stood at $103000.0 in 2022, then increased by 20.39% to $124000.0 in 2023, then tumbled by 55.65% to $55000.0 in 2024, then surged by 221.82% to $177000.0 in 2025.
  • Its Other Accumulated Expenses was $177000.0 in Q3 2025, compared to $183000.0 in Q2 2025 and $56000.0 in Q1 2025.